Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network.

Authors :: Marchesi F
Cerchiara E
Dessanti ML
Gumenyuk S
Franceschini L
Palombi F
Pisani F
Romano A
Spadea A
Pupo L
Annibali O
La Malfa A
Arcese W
Mengarelli A
Source :: British journal of haematology [Br J Haematol] 2015 Apr; Vol. 169 (2), pp. 293-6. Date of Electronic Publication: 2014 Nov 05.
Publication Year :: 2015

Subjects :: Biosimilar Pharmaceuticals administration & dosage
Biosimilar Pharmaceuticals chemistry
Chemistry, Pharmaceutical
Filgrastim
Granulocyte Colony-Stimulating Factor administration & dosage
Granulocyte Colony-Stimulating Factor chemistry
Hematologic Neoplasms therapy
Humans
Italy
Recombinant Proteins administration & dosage
Recombinant Proteins chemistry
Recombinant Proteins therapeutic use
Retrospective Studies
Transplantation, Autologous
Biosimilar Pharmaceuticals therapeutic use
Granulocyte Colony-Stimulating Factor therapeutic use
Hematopoietic Stem Cell Transplantation

Full Text Access

Tools